First topical pharmacologic therapy to enter clinical trials for ‘double chin’
Topokine Therapeutics has initiated dosing in a Phase 2, randomised controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly referred to as ‘double chin’. XAF5 Gel...
Read More
